Germline mutation status and therapy response in patients with homologous recombination deficient, HER2-negative early breast cancer: Results of the GeparOLA study (NCT02789332)

Hauke J, Ernst C, Fasching P, Jackisch C, Seither F, Klare P, Rhiem KE, Schmatloch S, Huober J, Stefek A, Seiler S, Uleer C, Doering G, Schneeweiss A, Denkert C, Untch M, Blohmer JU, Schmutzler RK, Loibl S, Hahnen E (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Annals of Oncology Elsevier

Publisher: ELSEVIER

City/Town: AMSTERDAM

Pages Range: S313-S313

Conference Proceedings Title: ANNALS OF ONCOLOGY

Event location: , ELECTR NETWORK

DOI: 10.1016/j.annonc.2020.08.298

Authors with CRIS profile

Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe

Involved external institutions

Universitätsklinikum Köln DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE) Universitätsklinikum Heidelberg DE Germany (DE) Universitätsklinikum Gießen und Marburg (UKGM) DE Germany (DE) Johanniter-Krankenhaus Genthin-Stendal DE Germany (DE) GBG Forschungs GmbH (German Breast Group) DE Germany (DE) Medionko-Institut GbR DE Germany (DE) Elisabeth-Krankenhaus DE Germany (DE) Universitätsklinikum Ulm DE Germany (DE) Sana Klinikum Offenbach DE Germany (DE) HELIOS Kliniken DE Germany (DE)

How to cite

APA:

Hauke, J., Ernst, C., Fasching, P., Jackisch, C., Seither, F., Klare, P.,... Hahnen, E. (2020). Germline mutation status and therapy response in patients with homologous recombination deficient, HER2-negative early breast cancer: Results of the GeparOLA study (NCT02789332). In ANNALS OF ONCOLOGY (pp. S313-S313). , ELECTR NETWORK: AMSTERDAM: ELSEVIER.

MLA:

Hauke, J., et al. "Germline mutation status and therapy response in patients with homologous recombination deficient, HER2-negative early breast cancer: Results of the GeparOLA study (NCT02789332)." Proceedings of the ESMO Virtual Congress, , ELECTR NETWORK AMSTERDAM: ELSEVIER, 2020. S313-S313.

BibTeX: Download